首页> 美国卫生研究院文献>Springer Open Choice >Disorders of the Optic Nerve in Mitochondrial Cytopathies: New Ideas on Pathogenesis and Therapeutic Targets
【2h】

Disorders of the Optic Nerve in Mitochondrial Cytopathies: New Ideas on Pathogenesis and Therapeutic Targets

机译:线粒体细胞病变视神经疾病:发病机理和治疗靶点的新思路。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Mitochondrial cytopathies are a heterogeneous group of human disorders triggered by disturbed mitochondrial function. This can be due to primary mitochondrial DNA mutations or nuclear defects affecting key components of the mitochondrial machinery. Optic neuropathy is a frequent disease manifestation and the degree of visual failure can be profound, with a severe impact on the patient’s quality of life. This review focuses on the major mitochondrial disorders exhibiting optic nerve involvement, either as the defining clinical feature or as an additional component of a more extensive phenotype. Over the past decade, significant progress has been achieved in our basic understanding of Leber hereditary optic neuropathy and autosomal-dominant optic atrophy—the two classical paradigms for these mitochondrial optic neuropathies. There are currently limited treatments for these blinding ocular disorders and, ultimately, the aim is to translate these major advances into tangible benefits for patients and their families.
机译:线粒体细胞病变是由线粒体功能紊乱引发的人类疾病的异质性群体。这可能是由于主要的线粒体DNA突变或核缺陷影响了线粒体机器的关键组件。视神经病变是一种常见的疾病表现,视力衰竭的程度可能很深,严重影响患者的生活质量。这篇综述着重于表现出视神经受累的主要线粒体疾病,作为定义性临床特征或作为更广泛表型的附加组成部分。在过去的十年中,在我们对Leber遗传性视神经病变和常染色体显性视神经萎缩的基本理解上取得了重大进展,这是线粒体视神经病变的两个经典范例。目前,对于这些致盲性眼疾的治疗方法有限,最终目的是将这些重大进展转化为患者及其家庭的切实利益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号